chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: if she touches she can know where she received the vaccine; uncomfortable; some positions are difficult to keep because has pain in the arm; fever; very very painful at the injection site; red at the injection site; swollen at the injection site; tenderness at the injection site; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (if she touches she can know where she received the vaccine), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (some positions are difficult to keep because has pain in the arm), PYREXIA (fever) and VACCINATION SITE PAIN (very very painful at the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 0L0ML0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced FEELING ABNORMAL (if she touches she can know where she received the vaccine), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (some positions are difficult to keep because has pain in the arm), PYREXIA (fever), VACCINATION SITE PAIN (very very painful at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE PAIN (tenderness at the injection site) and VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, FEELING ABNORMAL (if she touches she can know where she received the vaccine), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (some positions are difficult to keep because has pain in the arm), VACCINATION SITE PAIN (tenderness at the injection site) and VACCINATION SITE PAIN (soreness at the injection site) had not resolved and PYREXIA (fever), VACCINATION SITE PAIN (very very painful at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) had resolved.            Treatment of events was reported with acetaminophen (Tylenol, only first days).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: cannot move her arm and it is very painful; cannot move her arm and it is very painful; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (cannot move her arm and it is very painful) and PAIN IN EXTREMITY (cannot move her arm and it is very painful) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RIVAROXABAN (XARELTO), LEVOTHYROXINE SODIUM (SYNTHROID) and PARACETAMOL (TYLENOL) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced MOBILITY DECREASED (cannot move her arm and it is very painful) and PAIN IN EXTREMITY (cannot move her arm and it is very painful). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (cannot move her arm and it is very painful) and PAIN IN EXTREMITY (cannot move her arm and it is very painful) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Ice.   This case was linked to MOD-2021-044200, MOD-2021-044200 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received contain second dose information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Headache, Hot flush, Micturition urgency, Migraine
Clinical narrative: Migraine at the right side of the brain for 5 hours; hot/cold flashes; Unable to stand and had to crawl to the bathroom; Urinating urgency, urinated on herself and floor; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine at the right side of the brain for 5 hours), HOT FLUSH (hot/cold flashes), DYSSTASIA (Unable to stand and had to crawl to the bathroom), MICTURITION URGENCY (Urinating urgency, urinated on herself and floor) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included VITAMINS NOS for an unknown indication.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced MIGRAINE (Migraine at the right side of the brain for 5 hours), HOT FLUSH (hot/cold flashes), DYSSTASIA (Unable to stand and had to crawl to the bathroom), MICTURITION URGENCY (Urinating urgency, urinated on herself and floor) and HEADACHE (Headache). On 07-Mar-2021, MIGRAINE (Migraine at the right side of the brain for 5 hours) had resolved. At the time of the report, HOT FLUSH (hot/cold flashes), DYSSTASIA (Unable to stand and had to crawl to the bathroom) and MICTURITION URGENCY (Urinating urgency, urinated on herself and floor) outcome was unknown and HEADACHE (Headache) had resolved.            On follow-up, the patient stated that she had a migraine for 5 hours the night of the vaccine but it went way and the headache went away soon after. She reported having no other reaction. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up received on 21 June 2021 and updated outcome of event, Additional event added.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: sore arm; Headache; Extreme Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HEADACHE (Headache) and NAUSEA (Extreme Nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN and AJMALINE (CARDIA) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Extreme Nausea). On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with FAMOTIDINE (PEPCID [FAMOTIDINE]) at a dose of 1 dosage form; ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 1 dosage form and PEPPERMINT [MENTHA X PIPERITA] at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache) was resolving and NAUSEA (Extreme Nausea) had not resolved.            Treatment provide included bland diet, ginger ale, and ginger tea. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: TCR received and updated event(Sore arm) onset date
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication use was provided by the reporter. Treatment for dizziness was reported as meclizine 12.5mg on unknown dates. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow-up TCR: Patient reported all adverse events resolved. Declined to provide any further information and requested not to be called.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to event was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Arm soreness; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient stated he did not take any medication and did not visit his HCP. It is unknown if the patient received the 2nd planned dose scheduled on 08APR2021.
Sex: F
Vaccine: COVID19
Symptoms: Sneezing, Throat irritation
Clinical narrative: scratchy throat; sneezed; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat) and SNEEZING (sneezed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (scratchy throat) and SNEEZING (sneezed). At the time of the report, THROAT IRRITATION (scratchy throat) and SNEEZING (sneezed) outcome was unknown.            No concomitant medications and treatment medications were reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Reporter did not allow further contact
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Cough; Runny Nose; Sore Throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough) and RHINORRHOEA (Runny Nose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032MZ0A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced OROPHARYNGEAL PAIN (Sore Throat). On 11-Mar-2021, the patient experienced COUGH (Cough) and RHINORRHOEA (Runny Nose). On 11-Mar-2021, OROPHARYNGEAL PAIN (Sore Throat) had resolved. At the time of the report, COUGH (Cough) and RHINORRHOEA (Runny Nose) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Pyrexia, Tremor
Clinical narrative: he woke up shaking like crazy; he has joint pain (ankle, elbow); temperature; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (he woke up shaking like crazy), ARTHRALGIA (he has joint pain (ankle, elbow)) and PYREXIA (temperature) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced TREMOR (he woke up shaking like crazy) and ARTHRALGIA (he has joint pain (ankle, elbow)). 11-Mar-2021, the patient experienced PYREXIA (temperature). At the time of the report, TREMOR (he woke up shaking like crazy), ARTHRALGIA (he has joint pain (ankle, elbow)) and PYREXIA (temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 100 (High) high, 100.3 (High) high, 101 (High) high and 101.3 (High) high.         No concomitant medications were reported.  The patient self-treated with ibuprofen, twice.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Dizziness; Weakness; Chills; Mild headache; Muscle pain at injection site; Nausea; Vomiting; Fever; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Mild headache) and INJECTION SITE PAIN (Muscle pain at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Mild headache), INJECTION SITE PAIN (Muscle pain at injection site), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Mild headache), INJECTION SITE PAIN (Muscle pain at injection site), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown. Not Provided          The patient was taken to the ER for observation on 10 Mar21 from 10am-6pm.  The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nausea, Pyrexia, Vomiting
Clinical narrative: Dizziness; Weakness; Chills; Mild headache; Muscle pain at injection site; Nausea; Vomiting; Fever; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Mild headache) and INJECTION SITE PAIN (Muscle pain at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Mild headache), INJECTION SITE PAIN (Muscle pain at injection site), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Mild headache), INJECTION SITE PAIN (Muscle pain at injection site), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown. Not Provided          The patient was taken to the ER for observation on 10 Mar21 from 10am-6pm.  The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Injection site irritation, Pruritus, Swelling
Clinical narrative: injection site irritation; redness; itchiness; burning; swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE IRRITATION (injection site irritation), ERYTHEMA (redness), PRURITUS (itchiness), BURNING SENSATION (burning) and SWELLING (swelling) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE IRRITATION (injection site irritation), ERYTHEMA (redness), PRURITUS (itchiness), BURNING SENSATION (burning) and SWELLING (swelling). The patient was treated with BACITRACIN at an unspecified dose and frequency. At the time of the report, INJECTION SITE IRRITATION (injection site irritation), ERYTHEMA (redness), PRURITUS (itchiness), BURNING SENSATION (burning) and SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details included Bacitracin ointment.   This case was linked to MOD-2021-103479 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: Sore arm; Tingling to lower part of face; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PARAESTHESIA (Tingling to lower part of face) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia. Concomitant products included FAMOTIDINE, CLOPIDOGREL BISULFATE (PLAVIX), ATORVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PARAESTHESIA (Tingling to lower part of face). At the time of the report, PAIN IN EXTREMITY (Sore arm) and PARAESTHESIA (Tingling to lower part of face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient is in her 70's. Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Feels nauseous all the time but not vomiting; Tired; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Feels nauseous all the time but not vomiting) and FATIGUE (Tired) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004020A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced NAUSEA (Feels nauseous all the time but not vomiting) and FATIGUE (Tired). At the time of the report, NAUSEA (Feels nauseous all the time but not vomiting) and FATIGUE (Tired) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: TCR  was received on 04-May-2021: Outcome of events was updated as recovered/resolved, action taken was updated as n/a. It was reported that, no HCP care was sought by the patient.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 025J202A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 10-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved.            No concomitant product use was reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up received provided no new information.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Feeling hot, Headache, Neck pain
Clinical narrative: bone pain; warmth; neck pain; headaches; This spontaneous case was reported by a physician and describes the occurrence of BONE PAIN (bone pain), FEELING HOT (warmth), NECK PAIN (neck pain) and HEADACHE (headaches) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced BONE PAIN (bone pain), FEELING HOT (warmth), NECK PAIN (neck pain) and HEADACHE (headaches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, BONE PAIN (bone pain), FEELING HOT (warmth), NECK PAIN (neck pain) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Vaccination site erythema, Vaccination site mass, Vaccination site swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site mass (arm is lumpy under the injection site), vaccination site warmth (arm is hot under the injection site), vaccination site erythema (arm is very red under the injection site), vaccination site swelling (arm is swollen under the injection site) and myalgia (muscle aches) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# C48AAA for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 10, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 11, 2021, patient experienced vaccination site mass (arm is lumpy under the injection site), vaccination site warmth (arm is hot under the injection site), vaccination site erythema (arm is very red under the injection site), vaccination site swelling (arm is swollen under the injection site), myalgia (muscle aches) and bad headache. At the time of the report, vaccination site mass (arm is lumpy under the injection site), vaccination site warmth (arm is hot under the injection site), vaccination site erythema (arm is very red under the injection site), vaccination site swelling (arm is swollen under the injection site), myalgia (muscle aches) and bad headache outcome: unknown. No concomitant medication or treatment information reported. This case linked to MOD-2021-040834 (patient link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site mass (arm is lumpy under the injection site), vaccination site warmth (arm is hot under the injection site), vaccination site erythema (arm is very red under the injection site), vaccination site swelling (arm is swollen under the injection site) and myalgia (muscle aches) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# C48AAA for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 10, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 11, 2021, patient experienced vaccination site mass (arm is lumpy under the injection site), vaccination site warmth (arm is hot under the injection site), vaccination site erythema (arm is very red under the injection site), vaccination site swelling (arm is swollen under the injection site), myalgia (muscle aches) and bad headache. At the time of the report, vaccination site mass (arm is lumpy under the injection site), vaccination site warmth (arm is hot under the injection site), vaccination site erythema (arm is very red under the injection site), vaccination site swelling (arm is swollen under the injection site), myalgia (muscle aches) and bad headache outcome: unknown. No concomitant medication or treatment information reported. This case linked to MOD-2021-040834 (patient link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Gastric dilatation, Herpes zoster, Off label use, Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of GASTRIC DILATATION (Stomach is distended), OFF LABEL USE (Got her second dose (on 40th day after first dose)), HERPES ZOSTER (Flare up of shingles) and RASH (rash is back and she is sensitive in the affected area) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030a21a) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced OFF LABEL USE (Got her second dose (on 40th day after first dose)). On 09-Mar-2021, the patient experienced GASTRIC DILATATION (Stomach is distended), HERPES ZOSTER (Flare up of shingles) and RASH (rash is back and she is sensitive in the affected area). On 02-Mar-2021, OFF LABEL USE (Got her second dose (on 40th day after first dose)) had resolved. At the time of the report, GASTRIC DILATATION (Stomach is distended), HERPES ZOSTER (Flare up of shingles) and RASH (rash is back and she is sensitive in the affected area) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-040763.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hypoaesthesia, Hypoaesthesia oral, Lip swelling, Throat tightness
Clinical narrative: Nose and lip went numb; throat tightening; Nose and lip went numb; face flushed; Upper lip swollen/lips swelled again; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (face flushed), LIP SWELLING (Upper lip swollen/lips swelled again), HYPOAESTHESIA (Nose and lip went numb), THROAT TIGHTNESS (throat tightening) and HYPOAESTHESIA ORAL (Nose and lip went numb) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FLUSHING (face flushed) and LIP SWELLING (Upper lip swollen/lips swelled again). On 07-Mar-2021, the patient experienced HYPOAESTHESIA (Nose and lip went numb), THROAT TIGHTNESS (throat tightening) and HYPOAESTHESIA ORAL (Nose and lip went numb). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (intravenous) on 06-Mar-2021 for Adverse event, at a dose of UNK dosage form, prn and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (intravenous) on 07-Mar-2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, FLUSHING (face flushed), LIP SWELLING (Upper lip swollen/lips swelled again), HYPOAESTHESIA (Nose and lip went numb), THROAT TIGHTNESS (throat tightening) and HYPOAESTHESIA ORAL (Nose and lip went numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchy palms, face and feet; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itchy palms, face and feet) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Sarcoidosis (for nine years.).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy palms, face and feet). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchy palms, face and feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Patients symptoms were at extreme on 23 Feb 2021.   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting on and off for 3 hrs; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting on and off for 3 hrs) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa drugs).    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VOMITING (vomiting on and off for 3 hrs). At the time of the report, VOMITING (vomiting on and off for 3 hrs) outcome was unknown.            No relevant concomitant medications were provided.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Headache, Nausea, Vomiting
Clinical narrative: Stomach cramps; Diarrhea; Nausea; Vomiting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting) and HEADACHE (Headache). On 11-Mar-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (Diarrhea) and HEADACHE (Headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Eye swelling, Fatigue, Feeling abnormal
Clinical narrative: Felt weak; Felt herself "messed up"; Whole body pain; Can not move from the bad; Swelling in eyes; Swelling in hands; Headache; Fatigue/ Felt tired; Second dose was received on 10Mar2021 (on 36 day); Chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up") and PAIN (Whole body pain) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 10-Mar-2021 at 3:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (Chills). On 10-Mar-2021 at 3:00 PM, the patient experienced OFF LABEL USE (Second dose was received on 10Mar2021 (on 36 day)). On 10-Mar-2021 at 6:00 PM, the patient experienced EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), HEADACHE (Headache) and FATIGUE (Fatigue/ Felt tired). On 11-Mar-2021, the patient experienced ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up"), PAIN (Whole body pain) and MOVEMENT DISORDER (Can not move from the bad). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 10-Mar-2021 at 3:00 PM, OFF LABEL USE (Second dose was received on 10Mar2021 (on 36 day)) had resolved. At the time of the report, EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up"), PAIN (Whole body pain), MOVEMENT DISORDER (Can not move from the bad), HEADACHE (Headache), FATIGUE (Fatigue/ Felt tired) and CHILLS (Chills) outcome was unknown.            She treated symptoms also with ice bag topically on arm.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Movement disorder, Off label use, Pain, Peripheral swelling
Clinical narrative: Felt weak; Felt herself "messed up"; Whole body pain; Can not move from the bad; Swelling in eyes; Swelling in hands; Headache; Fatigue/ Felt tired; Second dose was received on 10Mar2021 (on 36 day); Chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up") and PAIN (Whole body pain) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 10-Mar-2021 at 3:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (Chills). On 10-Mar-2021 at 3:00 PM, the patient experienced OFF LABEL USE (Second dose was received on 10Mar2021 (on 36 day)). On 10-Mar-2021 at 6:00 PM, the patient experienced EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), HEADACHE (Headache) and FATIGUE (Fatigue/ Felt tired). On 11-Mar-2021, the patient experienced ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up"), PAIN (Whole body pain) and MOVEMENT DISORDER (Can not move from the bad). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 10-Mar-2021 at 3:00 PM, OFF LABEL USE (Second dose was received on 10Mar2021 (on 36 day)) had resolved. At the time of the report, EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up"), PAIN (Whole body pain), MOVEMENT DISORDER (Can not move from the bad), HEADACHE (Headache), FATIGUE (Fatigue/ Felt tired) and CHILLS (Chills) outcome was unknown.            She treated symptoms also with ice bag topically on arm.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Rash on his right elbow and right thigh, the rash itched; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash on his right elbow and right thigh, the rash itched) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 31L201 and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included VITAMIN E NOS for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Rash on his right elbow and right thigh, the rash itched). At the time of the report, RASH PRURITIC (Rash on his right elbow and right thigh, the rash itched) outcome was unknown.            No treatment information was provided
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site erythema, Vaccination site pain, Vaccination site scar
Clinical narrative: Burning inside at injection site; quarter-sized round ring described as "bull's eye" at injection site; Redness at injection site; Flu-like" aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like" aches), VACCINATION SITE SCAR (quarter-sized round ring described as "bull's eye" at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Burning inside at injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Lyme disease in 1999, Sjogren's syndrome, Psoriatic arthritis, Cancer (Cancer survivor) in 2011 and Allergy NOS since an unknown date. Previously administered products included for an unreported indication: INFLUENZA VACCINE.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like" aches). On 07-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site). On 08-Mar-2021, the patient experienced VACCINATION SITE SCAR (quarter-sized round ring described as "bull's eye" at injection site). On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Burning inside at injection site). On 07-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like" aches) had resolved. At the time of the report, VACCINATION SITE SCAR (quarter-sized round ring described as "bull's eye" at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Burning inside at injection site) had not resolved.            No relevant concomitant medications were provided.  No treatment information was provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Fungal infection, Headache, Pruritus
Clinical narrative: Itching in hands and feet; Headache would come and go; A little bit of tiredness; Yeast infection; This spontaneous case was reported by a consumer and describes the occurrence of FUNGAL INFECTION (Yeast infection), PRURITUS (Itching in hands and feet), HEADACHE (Headache would come and go) and FATIGUE (A little bit of tiredness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included Bell's palsy (5-6 years back.).    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced FUNGAL INFECTION (Yeast infection). On 25-Feb-2021, the patient experienced PRURITUS (Itching in hands and feet), HEADACHE (Headache would come and go) and FATIGUE (A little bit of tiredness). The patient was treated with MICONAZOLE for Yeast infection, at an unspecified dose and frequency. On 01-Mar-2021, FUNGAL INFECTION (Yeast infection) had resolved. On 02-Mar-2021, PRURITUS (Itching in hands and feet), HEADACHE (Headache would come and go) and FATIGUE (A little bit of tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states that her adverse reactions were minor and lasted for about 5 days. Patient concern is with the 2nd dose of the COVID-19 vaccine. She wants to know if there is a chance that she might have Bell's Palsy after receiving the 2nd dose.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up information received on 10-May-2021 and Reporter Contact information (E-mail) was added
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Peripheral coldness, SARS-CoV-2 test
Clinical narrative: Feet and hands were cold; Tested positive for COVID; A spontaneous report was received from a consumer concerning a female patient of unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive for COVID (COVID-19) and feet and hands were cold (peripheral coldness).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unspecified date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch Number: unknown) for prophylaxis of COVID-19 infection.  On an unspecified date, after the vaccination, the patient was tested positive for COVID and feet and hands were cold. No treatment information was provided.  Laboratory information included SARS-CoV-2 test (positive).  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, tested positive for COVID and feet and hands were cold, were considered as unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: feeling headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (feeling headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 012M20A) for COVID-19 immunisation.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (feeling headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, HEADACHE (feeling headache) outcome was unknown.            No concomitant product use was reported   This case was linked to MOD21-050404 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow-up received on 04-MAY-2021. Updated reporter information; Sender's Comments:  MOD21-050404:
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain radiated from the shoulder to the bottom), PERIPHERAL SWELLING (Extreme swelling) and PAIN IN EXTREMITY (Extreme Pain) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Concurrent medical conditions included Rheumatoid arthritis and Hypertension. On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (Pain radiated from the shoulder to the bottom), PERIPHERAL SWELLING (Extreme swelling) and PAIN IN EXTREMITY (Extreme Pain). At the time of the report, PAIN (Pain radiated from the shoulder to the bottom), PERIPHERAL SWELLING (Extreme swelling) and PAIN IN EXTREMITY (Extreme Pain) was resolving.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication not reported. Treatment medication not reported.